Global X Genomics & Biotechnology UCITS ETF USD Acc

The Global X Genomics & Biotechnology ETF invests in a diverse range of companies that are pioneering advancements in genomics and biotechnology. Its portfolio includes firms engaged in gene editing, genetic testing, biopharmaceutical development, and innovative medical technologies. The fund features both established biotech leaders and emerging companies specializing in areas such as CRISPR technology, personalized medicine, and agricultural biotechnology. By focusing on these cutting-edge sectors, the ETF aims to capture the growth potential driven by scientific breakthroughs and the expanding applications of genomics in healthcare and other industries.